JDisc Discovery is a comprehensive network inventory and IT asset management solution designed to help organizations gain clear, up-to-date visibility into their IT environment. It automatically scans and maps devices across the network, including servers, workstations, virtual machines, and network hardware, to create a detailed inventory of all connected assets. This includes critical information such as hardware configurations, software installations, patch levels, and relationshipots between devices.
One of the standout features of JDisc Discovery is its agentless discovery process, meaning it does not require the installation of any software on individual devices, reducing deployment time and minimizing network impact. It supports a wide range of protocols (e.g., SNMP, SSH, WMI) to gather data, making it compatible with diverse IT environments, whether they are Windows, Linux, or Unix-based.
Learn more
AthenaHQ is a cutting-edge platform for Generative Engine Optimization (GEO), designed to help brands optimize their visibility and performance across AI-driven search platforms like ChatGPT, Gemini, Perplexity, DeepSeek, Google's AI Overviews, and more. With Athena, companies can monitor AI perception, identify content gaps, and adjust strategies for better AI-driven discovery. AthenaHQ offers features like competitor analysis, sentiment analysis, and AI search volume tracking, making it easier for companies to align with the evolving search ecosystem. By understanding AI’s role in brand discovery, AthenaHQ empowers brands to stay ahead in the rapidly changing AI landscape.
Learn more
BenevolentAI
BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates.
Learn more
